Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation
- PMID: 15319863
- PMCID: PMC7199896
- DOI: 10.1086/422849
Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation
Abstract
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged, in November 2002, as a novel agent causing severe respiratory illness. To study sequence variation in the SARS-CoV genome, we determined the nucleic acid sequence of the S and N genes directly from clinical specimens from 10 patients--1 specimen with no matched SARS-CoV isolate, from 2 patients; multiple specimens from 3 patients; and matched clinical-specimen/cell-culture-isolate pairs from 6 patients. We identified 3 nucleotide substitutions that were most likely due to natural variation and 2 substitutions that arose after cell-culture passage of the virus. These data demonstrate the overall stability of the S and N genes of SARS-CoV over 3 months during which a minimum of 4 generations for transmission events occurred. These findings are a part of the expanding investigation of the evolution of how this virus adapts to a new host.
Similar articles
-
Characterization of a novel coronavirus associated with severe acute respiratory syndrome.Science. 2003 May 30;300(5624):1394-9. doi: 10.1126/science.1085952. Epub 2003 May 1. Science. 2003. PMID: 12730500
-
The Genome sequence of the SARS-associated coronavirus.Science. 2003 May 30;300(5624):1399-404. doi: 10.1126/science.1085953. Epub 2003 May 1. Science. 2003. PMID: 12730501
-
Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates.J Med Virol. 2005 Aug;76(4):435-40. doi: 10.1002/jmv.20379. J Med Virol. 2005. PMID: 15977248 Free PMC article.
-
Phylogenomics and bioinformatics of SARS-CoV.Trends Microbiol. 2004 Mar;12(3):106-11. doi: 10.1016/j.tim.2004.01.005. Trends Microbiol. 2004. PMID: 15058277 Free PMC article. Review.
-
Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.Infect Disord Drug Targets. 2007 Mar;7(1):29-41. doi: 10.2174/187152607780090739. Infect Disord Drug Targets. 2007. PMID: 17346209 Review.
Cited by
-
Characterizing 56 complete SARS-CoV S-gene sequences from Hong Kong.J Clin Virol. 2007 Jan;38(1):19-26. doi: 10.1016/j.jcv.2006.10.001. Epub 2006 Nov 16. J Clin Virol. 2007. PMID: 17112780 Free PMC article.
-
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China.Emerg Infect Dis. 2004 Oct;10(10):1774-81. doi: 10.3201/eid1010.040445. Emerg Infect Dis. 2004. PMID: 15504263 Free PMC article.
-
Genetic variability of human respiratory coronavirus OC43.J Virol. 2005 Mar;79(5):3223-4; author reply 3224-5. doi: 10.1128/JVI.79.5.3223-3225.2005. J Virol. 2005. PMID: 15709046 Free PMC article. No abstract available.
-
The SARS-CoV nucleocapsid protein: a protein with multifarious activities.Infect Genet Evol. 2008 Jul;8(4):397-405. doi: 10.1016/j.meegid.2007.07.004. Epub 2007 Jul 20. Infect Genet Evol. 2008. PMID: 17881296 Free PMC article. Review.
-
Use of whole-genome sequencing in the molecular investigation of care-associated HCoV-OC43 infections in a hematopoietic stem cell transplant unit.J Clin Virol. 2020 Jan;122:104206. doi: 10.1016/j.jcv.2019.104206. Epub 2019 Nov 16. J Clin Virol. 2020. PMID: 31783264 Free PMC article.
References
-
- Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science. 2003;300:1399–404. - PubMed
-
- Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–9. - PubMed
-
- Chinese SARS Molecular Epidemiology Consortium Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303:1666–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous